Eliem Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eliem Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Eliem Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -47 %, a 28.8% decline year-over-year.
  • Eliem Therapeutics, Inc. annual Return On Equity for 2023 was -31.5 %, a 2.6% increase from 2022.
  • Eliem Therapeutics, Inc. annual Return On Equity for 2022 was -32.3 %, a 57.5% increase from 2021.
  • Eliem Therapeutics, Inc. annual Return On Equity for 2021 was -76 %, a 151% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -47 -10.5 -28.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -13.3 +28.3 +68% Jan 1, 2024 Mar 31, 2024
Q4 2023 -31.5 +0.84 +2.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -33.6 -1.48 -4.61% Jul 1, 2023 Sep 30, 2023
Q2 2023 -36.5 -6.6 -22.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -41.6 -4.06 -10.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.3 +43.7 +57.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.1 Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.9 Apr 1, 2022 Jun 30, 2022
Q1 2022 -37.6 Jan 1, 2022 Mar 31, 2022
Q4 2021 -76 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.